This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Alex Stegh: Innovator in Cancer Research
Introduction
Alex Stegh is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. He has developed innovative methods and materials related to Bcl2L12 polypeptides, which play a crucial role in cellular processes.
Latest Patents
Stegh holds a patent for "Bcl2L12 polypeptide activators and inhibitors." This invention provides methods and materials related to Bcl2L12 polypeptides and their biological activities. Specifically, it includes methods for identifying activators and inhibitors of Bcl2L12 polypeptide activities, such as blocking apoptosis and promoting cell growth and transformation. Additionally, the invention offers methods for treating mammals with cancer.
Career Highlights
Alex Stegh is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies.
Collaborations
Stegh has collaborated with notable colleagues, including Ronald A. Depinho and Lynda Chin, who are also influential figures in the field of cancer research.
Conclusion
Alex Stegh's innovative work in the realm of cancer research, particularly through his patent on Bcl2L12 polypeptides, showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer.